Meet the Expert - The Association of Physicians of...
Transcript of Meet the Expert - The Association of Physicians of...
Dr. D.P. PundeM.D. (Medicine)
Punde Hospital, Mukhed, Dist. Nanded (M.S.)
e-mail:[email protected] 2008Kochi
Meet the ExpertManagement of
Snake Bite
11th January, 2008
Hall H
17.00 to 18.30 hrs.
Contents
1. Snake Bite ......................................................................................................................... 5
Meet the ExpertManagement of
Snake Bite
• Snakebite isaacute life threatening time limitingmedicalemergencyaoccupationalhazardoftenfacedbyfarmlabourersandfarmers.ItisinendemicformallovertropicalcountrieslikeIndia.
• SnakebiteisaforgottentopicinIndia.
Gravity• 2.5lakhssnakebitesperyearinIndia.
• 35,000to50,000deathsperyearduetosnakebiteinIndia.
• HighmortalityinMaharashtra,upto2000deathsperyear
• Highmortalityinruralpopulation.
• Deathfiguremaybehigh.
• 3000speciesofsnakesaredistributedworldwide.500arevenomousspecies52venomousspeciesarefoundinIndiansubcontinent.
Poisonous Snakes
Elapids Neurotoxic :
Cobra, King Cobra, common krait, banded krait, coral, Spitting cobra & Mamba.
Vipers Vasculotoxic :
Pitless -Russell’sViper&Saw-scaled
Pit -Bamboopitviper,Hump-nosedpitviper,Malbarpitviper
Sea snakes Myotoxic
Bigfour
Cobra Predominantlyneurotoxic
Krait Predominantlyneurotoxic
Russell’sViper Predominantlyvasculotoxic
Saw-scaledviper Predominantlyvasculotoxic
Cobra : (NajanajanajaorNag):-foundallover India,upto6 feet in length ,Wheatyorblackishcolored,formsahoodbearingaspectaclemark(Bicyelet,MonocyeletorAcyelet),bitescommoninmorning&evening&predominantlyneurotoxic.
Common Krait (BungarauscaeruleusorcommonkraitorManyar):-FoundalloverIndia,upto3feetinlength.glistening black, having white bands darker towards tail, central hexagonalscales,nocturnal,predominantlyneurotoxic,Suryakandar.
Russell’s Viper (Daboiarussellii,Ghonus,Parad):-FoundalloverIndia,upto5.5feetinlength,Stout,Brownorbuffcoloured&hasthreerowsofblackdiamondshapedspotsonback,triangularheadwithvmark,itmakesaterrifichissingsoundwhenabouttobite&bitemaybeindayornighthours,predominantlyvasculotoxic
Snake Bite
6 APICON 2008 Kochi
Saw-scaled viper (EchiscarinatusorphoorsaorJilebiSnake):-FoundalloverIndia,upto1.5feet,Brownishcoloured,triangularheadwithwhitearrowmark,bitemaybeindayornighthours,predominantlyvasculotoxic.
Non-poisonous Snakes
01.RatSnake(Colubermucosus) 02. Trinket(Elaphe helena)
03.CommonWolfSnake(Lycodon aulicus) 04.WaterSnake(CheckeredKeelBack)
05.Python(Python molurus molurus) 06.EarthBoa(Eryx johnii)
07.CommonSandBoa(Eryx conicus) 08.GrassSnake(Macropisthodonplumbicolor)
09.Bronzebacktreesnake(Dendrelaphis tristis) 10.BandedRacer(Argyrogenafasciolatus)
11. Common cat snake (Boigatrigonata) 12. Common kukri snake (Oligodonamensis)
13.Strippedkeelback(Amphiesmastolata) 14.VineorWhipsnake(Ahaetulla)
Anatomy of the snake
Snakeisavertebrate,coldbloodedreptile,hastwoeyeswithouteyelids,twonostrils,noears,biprongedtongue,70–80teeth&twofangsinvenomoussnakes,100-200vertebrae&200-400ribs,lungs,kidneys,testis,etc.,Nodiaphragm,heart3chambered,nosweatglands.
Fangs of Snakes
Cobra & Krait Short,2-4mm&grooved,erected
Viper Long,12-15mm&canalisedlikehypodermicneedle,folded
Snake Venom
Containsnumberof toxinsandenzymes.It isaclear transparent,amber tinted fluidandcontains.
1. Neurotoxin (Predominant in Elapids)
2. Cholinesterase (Predominant in Elapids)
3. Haemolysins (PredominantinViper)
4. Thromboplastin (PredominantinViper)
5. Fibrinolysins
6. Proteolysins
7. Cardiotoxin
8. Agglutinins
9. Coagulase,Hyaluronidaseetc.
• 10outof26ineachvenomwithseasonal(Venomismorelethalinwinterthansummer)&Regionalvariationsinpotency.
Factors Affecting Snake Bite
1. Site:-Bitesaremorecommoninlower&upperlimbs,bitesclosertobrainaremoredangerous.
Factors Affecting Snake Bite
2. Occupation:BitesaremorecommoninFarmers&Labourers
3. Time of bite :-Nocturnalbitesareserious.Cobra:-Morningandevening,Krait:-Night,Vipers:-day&nighthours.
4. Size of the snake :-Newbornsofsnakesareequallydangerouslikeadults.
7Snake Bite
Pathophysiologic basis of clinical spectrum in ophitoxemia
Snake bite
Venom
Systemic absorption via lymphatics
Spread facilitated by hyaluronidase
Venom in blood stream (Ophitoxemia) Pooling of blood Activation of Directo cytolytic Alteration of in microcirculation kinin & bradykinin action coagulation system activity Ischaemia fibrinolysis Haemolysis
capillary permeability Loss of plasma OEDEMA Local necrosis & blood
circulating vol. 2°Infection Bleeding Shock
DEATH
Venom in blood stream (Ophitoxemia) Neurotoxin Cardiotoxin Myotoxin Nephrotoxin Selective Cardiac arrest K+ Myoglobulinuria ARF Neuromuscular release block
Paralysis
Respiratory Arrest DEATH
8 APICON 2008 Kochi
5. Condition of the snake:-Ifrecentlycastedsevereenvenoming.
6. Type of fangs :- More venom is injected in vipers.
7. Size of the pt.:- Severe envenoming in children due to less body surface area.
8. Clothes, shoes:- Less envenoming.
9. Sleep :- Slow envenoming.
10. Primary aids :- If received less mortality & if not high mortality.
11. Bite Time since :- If delayed admission high mortality.
Diagnosis of Snake Bite
• H/osnakebite-seeforA,B,Cofthept.Ask3questionstopt.–
• Whichisthesiteofbite?,Whatistimesincebite?,whethersnakeisseenornot?
• UnknownbitetoS/osnakebite
• Examofkilledsnake,showingspecimen.
Observed Bite Marks Variations
Poisonous :
1. Twofangmarksonlywithorwithoutoedema
2. TwoFangmarks+othermultipleteethmarks+oedema
3. Singlemarkonlywithorwithoutoedema
4. Onlyabrasion
Distribution of Total Bite Cases as per Site of BiteSite Neurotoxic Vasculotoxic Non Poisonous Unknown Total % Fatal
Upperlimbs 48 126 83 127 384 43.24 9
Lowerlimbs 51 182 123 126 482 54.28 10
Trunk 1 2 0 Nil 3 00.34 Nil
Head&Neck 2 3 Nil 1 6 00.67 1
Penis 2 Nil Nil Nil 2 00.23 Nil
Glutelarea Nil 1 Nil 1 2 00.23 Nil
Site Not Detected 9 Nil Nil Nil 9 01.01 Nil
Total 113 314 206 255 888 100.00 20
*ManagementofSnakebiteinruralMaharashtra:A10yearexperience,D.P.Punde,NMJI,VOL18,No.2,2005,71-75
Occupationwise Distribution of Bite CasesNo.of total cases 888
Sr Occupation Poisonous Non Poisonous Unknown Total % of Total Cases
1 Child 12 4 6 22 2.48
2 Labourer 119 72 68 259 29.17
3 HouseWife 117 58 99 274 30.86
4 Farmer 159 69 80 308 34.68
5 Student 16 3 1 20 2.25
6 Service 1 0 1 2 0.23
7 Business 3 0 0 3 0.34
Total 427 206 255 888 100.00
*ManagementofSnakebiteinruralMaharashtra:A10yearexperience,D.P.Punde,NMJI,VOL18,No.2,2005,71-75
9Snake Bite
5. Twoabrasionswithorwithoutoedema
6. Onlyecchymoticpatch
7. Localbloodoozing
8. Nomarksseen
Observed Bite Marks Variations
Non-poisonous :
1. Multiple teeth marks
2. Singlemark
3. Onlyabrasion
4. Multipleabrasions
Clues for Diagnosis
Non-poisonous : (Snakenotbrought)
H/osnakebite,NoS/oenvenoming,Poisonous:(H/osnakebitebut Snakenotbrought&S/oenvenoming)
Saw scaled Localoedema+bleedingrare.
R. viper Local+bleedingdiathesis
Krait Minimalornolocalsigns+slowneuroparesis
Cobra Local+fastneuroparesis
Clues for Diagnosis
UnknownBite: H/ounknownbite,Observe(24to48hrs.)
* IfS/osnakeenvenoming.-snakebite
*NoS/osnakeenvenooming.-unknownbite.
Dry Bite : H/osnakebite,NoS/oenvenoming,bittensnakeispoisonous
Clinical Syndromes
Syndrome 1- Local envenoming (swelling etc) with bleeding/Clotting disturbances –Viperdae (all species)
Syndrome 2
- Localenvenoming(swellingetc)withbleeding/clottingdisturbances,Shockorrenalfailure–Russell’sviper(andpossiblysaw-scaledviper–echisspecies–insomeareas.
- Withconjunctivaloedema (chemosis) andacutepituary insufficiency–Russell’sviper,Myanmar,NEIndia
- Withptosis,externalopthalmoplegia,facialparalysisetcanddarkbrownurine–Russell’sviper,SriLankaandSouthIndia
Syndrome 3 –Localenvenoming(swellingetc)withparalysis–CobraorKingcobra
Syndrome 4 –Paralysiswithminimalornolocalenvenomingbiteonlandwhilesleepingoutside– Krait.Biteinthesea–seaSnake
Syndrome 5 –Paralysiswithdarkbrownurineandrenalfailure:
-Biteonland(withbleedingandclottingdisturbance)–Russell’sviper,SriLanka/SouthIndia
10 APICON 2008 Kochi
-Biteinthesea(nobleeding/clottingdisturbances)–SeaSnake
Cobra bite - Symptoms & Signs
Majority of pts. Present within one hr.
Giddiness,Localoedema,Ptosis,Ophthalmoplegia,Heavinessinlimbs,Dysarthria,Dysphagia,Abd.Pain,Convulsions,Quadriparesis,Respiratoryparalysis,Death.
Note : fast development of signs (10 min to 2 hours) and fast recovery
Krait bite - Symptoms & Signs
Minimalorno local signs ,Abd.Pain (High indexof suspicion shouldbe there),Ptosis,Dysarthria,Dysphagia,Chestpain,Quadriparesis,Respiratoryparalysis,death.
Note :
1. Slowdevelopmentofsignsgenerallywithin3to4hrs.butdelayedsignsobservedupto56hrs.
2. Slowrecovery
3. Worsttypeofsnakebite,moredangerousthancobra.
Russell’s Viper bite - Symptoms & Signs
• Sev.Localpain,localbleedingstartssoonafterbite.
• Rapidlyprogressiveoedema,regionaltenderlymphadenopathy
• Nausea,vomiting
• Collapse,shock
• Bleeding-gum,tongue,Haematemesis,Hemoptysis,P/R,P/V,intracranial,petichae,purpura,echymoses,conjunctival,oldwounds,venepuncturesitesbleeding.
• S/oneuroparesisinfewcases
• Convulsions,coma
• DVT
• Renalfailure
• Death
Saw-Scaled Viper bite Symptoms & Signs
• Localslowprogressiveoedema
• Systemicsignsrare
• Bleedingrare
• Mortalityless
Sea Snake
• Usuallypainlessbiteandteetharefrequentlypresentinthewound
• Nolocalswellingorinvolvementoflocallymphnodes.
• Headache,thirstgeneralizedaching,stiffness,tendernessofmusclesandtrismus.
• Generalizedflaccidparalysislikeelapidneurotoxicity
• Generalizedrhabdomyolysis.
• Myoglobinemiaandmyoglobinuriaafter3to8hours.
• Serum/PlasmaappearsbrownishandUrinedarkreddishbrown(Coca-cola)colored.
11Snake Bite
• ARF,Hyperkalemiaandcardiacarrest.
Complications of Snake Bite
Respiratoryparalysis :Cobra&KraitFastinCobra
Shock&Bradycardia :Mainlyinvipers
Bleedingdiathesis&ARF :Russell’sviper,rareinsaw-scaledviper(inMarathwada,M.S.)
Non-healingulcers :Cobra&viper
Delayed :Pituitarydysfunction,persistenceofswellinginvipers.
Analysis of Poisonous Snake Bite Cases at Punde Hospital, Mukhed, Nanded (M.S.),
Total Cases = 427
Period 1992 to 2001 (Retrospective Study)Type of Snake No. of Cases Respiratory
Paralysis ARF ASV Anaphylactic ASV Dose Referred
Cases Death
Cobra 71 36(50.71%) Nil 12 40to320(156) 10 13
Krait 42 13(30.95%) Nil 08 40to250(154) 08 03
Russell’s
Viper40 Nil 12
(30%) 08 20to250(126) 20 04
Echis 274 Nil Nil 22 20to240(040) 08 Nil
Total 427 49 12 50(11.71%) 46 20(4.7%)
Complications of Snake BiteComplication Type of snake-bite Total
Neurotoxic (n=113) Vasculotoxic (n=314)
Acute
Respiratory paralysis 49 0 49
Cardiac complications
Shock 2 20 22
Bradycardia 3 9 12
Pulmonary oedema 3 0 3
Bleedingdiathesis 0 18 18
Acuterenalfailure 0 12 12
Gangrene 0 1 1
Subcutaneousemphysema 1 0 1
Therapy-related
Antisnakevenomanaphylaxis 11 39 50
Severe 8 28 36
Delayed
Non-healingulcer 25 6 31
Contracture 2 0 2
Vocal cord adhesions 1 0 1
*ManagementofSnakebiteinruralMaharashtra:A10yearexperience,D.P.Punde,NMJI,VOL18,No.2,2005,71-75
Investigations
CBC,BT,CT-20minWBCT,Urine,ECG,Bl.Grouping,LFT,Bl.Urea,Sr.creatinine,Sr. Na+, Sr. K+, X-ray chest, Coagulation profile (at higher center), Blood gas analysis (at higher center).
12 APICON 2008 Kochi
WBCT (Cont..) 20 Min WBCT (Whole blood clotting time) WHO/SEARO Guidelines
• Simple,bedsidegoldstandardtesthavingdiagnosticvalue.
• Draw2ccvenousbloodofpt.&placeinanewtesttube.
• Leaveundisturbedfor20mins.atambienttemp.
• Tipthetubeonesafter20mins.
• Ifthebloodisstillliquid(unclotted)andrunsout,thepatienthashypofibrinogenaemia(“incoagulableblood”)asaresultofvenom-inducedconsumptioncoagulopathy.
• IntheSoutheastAsianregion.Incoagulablebloodisdiagnosticofaviperbiteandrulesoutanelapidbite.
WBCT 20 Min WBCT (Whole blood clotting time) WHO/SEARO Guidelines
• Warning!Ifthevesselusedforthetestisnotmadeofordinaryglass,orifithasbeenusedbeforeandcleanedwithdetergent,itswallmaynotstimulateclottingofthebloodsampleintheusualwayandtestwillbeinvalid.
• If there is anydoubt repeat the test induplicate includinga “control” (blood fromahealthy person).
• Performtestonadmission&6hrly.
• Change in WBCT is observed within 30 min or upto 6 hrs due to initial hepaticcompromise.
• ASVmonitoringisdonewiththehelpofWBCT.
Management
Difficultinruralset-up
Due to :
• Lackoffacilities,equipments&trainedstaff
• llliteracy,misbeliefs,quacks&poverty
• Improperprimaryaid
• Delayinadmissions
• Highcosttherapy(400to500Rs/Vial)
Management - Primary Aids
• Immobilisationofpt.-Avoidfright&flight
• Keepbittenpartbelowheartlevel
• Allayofanxiety(Lessinpaedatricgroup)
• Tourniquet,Pressureimmoblisation(CrepeBandageinKraitbite)
• Careofthewound
• Shiftingofpt.toproperhospital
• VitaltimeshouldnotbewastedwithMantriks&Quacks.
Be AlertTourniquetshouldnotbereleasedimmediatelybeforeadministrationofASVbecausepatientmaydevelopfast&severeenvenoming.
13Snake Bite
Management - General T/t
• I.V.line
• TT,antibiotics,anti-inflammatory,anxiolytics,don’tallowpt.tosleep
• Observationminimumfor24hrsineverycase,ifdoubtobserveupto48hrs.
• Dieticadvise:-Normaldietifnocomplications,NBMifpt.hasvomitings,GIbleedingorneuroparesis,lowK+&calculatedfluidsifrenalfailure.
Management - Specific ASV Schedule
• IVrouteonly,polyvalentfromHaffkin,SerumInstitute.
• DoseofASVisstillempirical.
• PreviousMortalitywas4.7%&nowitisless.
• Averageyieldofvenomperbite:
Cobra60mg.,R-Viper63mg.,Krait20mg.,Saw-scaled13mg.(Fataldose12mg.,15mg.,6mg.,8mg.Respectively.1mlofPolyvalentASVwillneutralize0.6mgCobra&R-Viper,0.45mgofKrait&Saw-scaledvenom.
Cobra :
• 10vialsin200mlnormalsalineIVdripin1sthrasaloadingdose.
• 2to5vialsaspertheneedbymicrodripinfurtherperiodi.e.24hrsmoreaftercompletereversalofneuroparesistopreventrecurrence.
Krait :
• 10vialsin200mlnormalsalineIVdripin1sthr&
• 2to5vialsinfurther24hrsbymicrodrip.
• Ifpt.isonventilator,Neostigmine&largedoseofASVisnotneeded.
Saw-Scaled Viper :
• 2to4vialsin200mlnormalsalineIVdripin1st hr
• 2vialsinfurther24hrs.bymicrodrip.
• ASVisindicatedonlyifswellingoccurswithin1hr.ofbiteorbloodisincoagulableby20WBCT.
• Ifpt.comeslatewithabnormal20WBCTgiveASV.
Russell’s Viper :
• 10vialsin200mlof5%glucosein30mins.
• Ifactivebleedingdonotstopwithin30mins.give5vialsin200ml5%glucoseover2hrs.
• 5vialsbymicrodripinfurther24hrs.
• Observept.clinically&by20WBCT6hrly.
• Ifbleedingpersistsorbloodisincoagulablegivefreshblood.
• MaintenanceASVshouldbegivenforfurther24hrsafterbloodbecomescoagulabletopreventrecurrence.
ASV Schedule (Contd…)
• Doseinpediatricsissameasadults
• Lowdose&adequatetherapyshouldbeusedduetocost,reactions&shortsupply.
14 APICON 2008 Kochi
• RegionwisechangeinASVdosesduetovariationinvenomtoxicity
• Doserequiredforsaw-scaledviperinMarathwadaislessascomparedtoKokan&SouthIndia
ASV Sensitivity Test
20to30minpriortotherapy,Notalwaysreliable,Notpossibleinemergency,Manystudieshavenotrecommended.13%anaphylaxisinpersonalexperiencepreviously.
Nowweareusingprophylactic0.25ccsubcut.AdrenalinebeforeASV(ifnotcontraindicated)&observeddrasticreductioninanaphylaxis
ASV Reactions
1. EarlyAnaphylacticReaction
- within10to180mins,mildtosevere
- Treat.–adrenaline(IM),steroids,antihistamincs.
RinsingofemptysyringofadrenalineinIVdripisbeneficialintreatingsevereshock
2. Pyrogenic Reactions.
- within1to2hrs.aftertreat.
3. Late(SerumSickness)Reactions.
- From1to12days,rare
- Treat.Oralsteroids&antihistamincs
ASV Schedule and special situations
• DelayedadmissionwithbleedinggivefulldoseofASV.
• DelayedadmissionnoexternalbleedingbutincoagulablebloodgivefulldoseofASV.
• Ifrecurrenceofsymptoms&signsgive50%ofloadingdoseofASV.
T/t of Neuroparesis
• Duetopre&postsynapticblockadeinKrait&postsynapticblockadeinCobrabite.
• Neostigmine&Atropine-1/2hrly6dosesofneostigmine(50mcg./kg)andAtropineaspertheneedinCobra&Kraitbite
• DrasticimprovementinCobrabite
• NeostigminenotmuchbeneficialinKraitbite.
Kind Attention
Fixed&dilatedpupilinneurotoxicsnakebiteisasignofenvenomingandnotthesign of brain death. Patient may recover totally.
T/t of Respiratory Paralysis
• Intubation&ventilation(AmbuBagorVentilator)
• Oxygenation
• Careoftubeetc.
T/t of Cardiac Complications
Shock : IVfluids,dopamine&dobutamine
Arrythmias : Orciprenalineforsev.bradycardiaifnotrespondingtoatropine(1.2mg.)
Myocardial Infarction : TreatofInfarct.
15Snake Bite
Cardiac arrest : Cardiac resuscitation
T/t of Hyperkalemia S.K+ > 5
• CalciumgluconateIV,Sodiumbicarbonate.
• Dextrose&insulin.,Salbutamolinhalation.
• Dialysis.
T/t of Hypoglycemia
InR.Viperbite-IVglucose&Steroids
T/t of Renal Complications
• Renalangletendernessisaearlysign
• Properhydration
• ProphylacticfrusemideorTorsemide.
• Diuretics–500mgoffrusemidecanbetriedthroughIVdripwithin24hrsinARF
• Dialysis(Haemo/PD)
T/t of Bleeding Complications
• Fluids,ranitidine,sucralfate
• Useofbortrophaseðamsylate
• Bloodtransfusion,FFP.
• Platelettransfusion.
T/t of Non- Healing Ulcers, Contractures, gangrene
• Surgicaldebridement,amputation
• Proper,asepticdressing
• Skingrafting,plasticsurgery
Pregnancy & Envenoming
• Treatedwithsameprotocol,nomaternal&foetalmortalityinourexperience
Delayed Complications
• Persistenceofswellinginviperbite
• Serumsickness
• Pituitarydysfunction–Sheehan’ssyndromeNotobservedinourstudy.
• Hypothyrodism
Recurrence of Systemic Envenoming
• Seenincobra&viperswithin24to48hoursorevendaysafterinitialresponse.
• Duetoabsorptionofvenomfromthedepotatthesiteofbite.perhapsduetocorrectionofshock,hypovolaemiaetc.
• Aftereliminationofantivenom.HalflifeofIgG35-70hrs,Fab12-18,F(ab)280-100hrs.andvenommayreappearincirculationaslongas130hrs.
• NeedoflongactingmonovalentASV.
Cause of Death
• Prolongedrespiratoryarrestleadingtocerebralanoxia&braindeathinelapidaebite.
16 APICON 2008 Kochi
Flow Chart of management of snake bite
ASV–antisnakevenom,N-Neostigmine,A-Atropine
RF-Renalfailure,DIC-Disseminatedintravascularcoagulation
History of snake bite
Absent Local edema Present
Floor bed
Abdominal pain
Neuroparalysis
Neuro- paralysis
• Bleed • DIC • Shock • RF
Bleeding +
ASV N+A
ventilator
ASV dialysis blood -
transfusion
ASV Blood
transfusion
ASV ventilator
N+A Management
Krait
Cobra
R.viper
Ecchis
-
• Shock, DIC and ARF in vipers (bite cases referred to tertiary care centre werefollowed).
Analysis of Bite cases from 01-01-2003 to 31-08-2004 Total Bite Cases = 206 ( Snake Bite 144 + Unknown Bite 62 )
Snake Bite Cases = 144 (Poisonous 68 + Nonpoisonous 76) Analysis of Poisonous Snake Bite Cases
Type of Snake
No of Cases
Dry Bite
ComplicationsASV
ScheduleASV
ReactionsVentilation
Time
Referred Cured Death Res. Paraly ARF
Cobra 22 Nil 10(45.45%) Nil 80to340
(145ml.) 02 1to34(6.12hrs) Nil 22 Nil
Krait 09 02 02(22.22%) Nil
120to180
(151 ml.)Nil 24to56
(42.85hrs) Nil 09 Nil
Russell’sViper 15 01 Nil 01
(7.14%)60to200(140ml.) 02 - 02 14 01
Echis 22 02 Nil Nil 20to60(47ml.) 01 - Nil 22 Nil
Total 68 05 12 01 - 05(7.93%) - 02 67 01
(1.58%)
0.25ccsubcutadrenalineusedpriortoASV
17Snake Bite
Analysis of Bite Cases at Punde Hospital, Mukhed, Nanded (M.S.) 1/9/2004 To 31/12/2007
Total Cases = 450 (Snake Bite 382 + Unknown Bite 68) Snake Bite = 382 (Poisonous 205 + Nonpoisonous 177)
Poisonous Snake Bite = 205 (Cobra - 66 / Krait - 19 / Rusell’s Viper - 95 / Echis - 25) Analysis of Poisonous Vasculotoxic Snake Bites (Group-A)
Type of Snake
No. of Cases
Dry Bite ARF
Bite to ARF time interval in hrs.
ASV dose given in
ml
ASV Reactions prior (0.25
cc) sc Adrenaline
given
Time required for
Normalisation of cloting time
in hrs.
Refered
cases
Mortality
Russell’s
Viper95 03 19
(20.66%)12to96(32.11)
60to240(152.10) 09 6to48(16.90) 24 07
Echis Carinatus 25 01 Nil - 40to60
(44.11) 01 12 hrs Nil Nil
Total 120 04 19 10(8.62%) 24(20.68%)07(13.14%)
Analysis of Bite Cases at Punde Hospital, Mukhed, Nanded (M.S.) 1/9/2004 To 31/12/2007
Total Cases = 450 (Snake Bite 382 + Unknown Bite 68) Snake Bite = 382 (Poisonous 205 + Nonpoisonous 177)
Poisonous Snake Bite = 205 (Cobra - 66 / Krait - 19 / Rusell’s Viper - 95 / Echis - 25) Analysis of Poisonous Neurotoxic Snake Bites (Group – B)
Type of Snake
No. of Cases Dry Bite Resp.
Paralysis
Bite to Resp.
Paraly-sis time interval in hrs.
ASV dose given in
ml
ASV Re-actions
Mean Ventila-
tion time in hrs.
Time required for re-
versal of Neuropa-ralysis in
hrs.
Ref-ered cases Mortality
Cobra 66 3 24(36.36%)
1/2to4.5(1.37)
100to240(132.25) 03 2to30
(8.33)1to30
(5.0) 1 01
Krait 19 Nil 08(42.11%)
2½to7
(4.0)100to180
(146.31) Nil 14to80(46.37)
8to96(33.55) Nil Nil
Total 85 3 32(39.02%) 3(3.66%) 1(1.22%) 1(1.22%)
Analysis of table A & B
• MortalitywashigherinVasculotoxicthanNeurotoxicgroup.
• BitetoASVintervalwashigherin7fatalcasesofVasculotoxicgroup.(6hr,3hr,12hr,8hr,41/2hr,2hr,4hr)indicatingneedofearlyadministrationofASV.
• CauseofdeathinVasculotoxicgroupwasrefractoryshockleadingtoARFandneedsmoreresearch(referredcaseswerefollowed)Mortalitywasverylowinneurotoxicgroupdue toearlyadmissions, adequateandoptimumASV,anticholinesterasesand timelyartificialventilation.
• Earlyadmissionswereduetocontinuousmassawarenessprogrammesconductedbyusin rural areas.
• Prioruseof0.25ccsubcutaneousadrenalineshowedsignificantreductioninincidenceofASVreactions.
• A&Bgrouptakentogether:
• ASVReaction -6.50%
• Mortality -4.04%
18 APICON 2008 Kochi
Analysis of A & B groups shows that 80% of Vasculotoxic and 98% of Neurotoxic •snake bite cases can be managed successfully in rural setup.
Health Education
• Responsibilitiesofphysiciansare:
• EducationofGPs
• Educationofsociety
Education of GPs :
• Diagnosis
• Primaryaid
• Educationofbasiclifesupport
• Properreferral
• Commontendencyisnottotreat&onlyrefertoGovt.hospitals.Thisshouldbechanged&primaryT/tshouldbegiven&delayinfurtheradmissions&complicationsshouldbeavoided
Health Education
Education of society About :
• Primaryaid,misbelief,quacks
• Properclothing,wearingshoes.
• Useofstick&torchinnighthrs.
• Sleepinghabits
• Controlofrodents
• Keroseneswabsassnakerepellant
• AdviseaboutRCCconstructionifpossible
• Adviseaboutplanitationaroundhouses
• Killingofsnakes(controversial)
• Carefulhandlingofdeadsnakes
• Masseducationthroughawarenesscampsinruralareas
Conclusions
• Cobra,Krait,R.viper&Saw-scaledviperarepoisonoussnakes
• Mortalityishighduetoilliteracy,misbeliefspovertyetc.
• InviewofCPAriskofASVtherapyshouldbeexplainedtopatientandrelatives.Benefitshould exceed the risk.
• ProphylacticadrenalineifnotcontraindicatedshouldbeusedLowadequateASVtherapyshouldbeappliedconsideringcost&shortsupply.
• Properprimaryaid,earlyadministrationofASV,properuseofanticholinesterases&timelyendotracheal intubationwithAmbubagorventilatorare important for savinglife.
19Snake Bite
Take Home MessageCatchabreath
Savethelife
Recommendations
• Declarationofsnakebiteasanotifiableoccupationaldisease.
• EstablishmentofNationalprogrammeforsnakebite.
• EducationofGPsbyHealthDept.
• EducationofsocietybyNGOs&HealthDept.
• NeedofmoreASVinRuralGovt.HospitalsandfreesupplyofASVtoprivateHospitalsbyGovt.
• Needofvenomdetectionkits(VDK)andmonovalentlongactingASV
• Researchaboutpharmacologicalantidotetovenomandchemicalreceptors.
• Insurance of Labourers & Farmers should be considered & promoted by theGovernment.
• Establishmentofregionalresearch,anti-venom&Snakebitetreatment centre.
Our Experience Analysis of Bite Cases Treated
Table 1
Period Poisonous Snake Bites
Nonpoisonous Snake Bites Unknown Total Death
01/01/1992to31/12/2001 427 206 255 888 20
01/01/2002to31/12/2002 47 34 47 128 0
01/01/2003to31/08/2004 68 76 62 206 01
01/09/2004to31/12/2007 205 177 68 450 08
Total 747 493 432 1672 29
20 APICON 2008 Kochi
Table 2
TypeofSnakePeriod
Total01/01/1992to31/12/2001
01/01/2002to31/12/2002
01/01/2003to31/08/2004
01/09/2004to31/12/2007
Cobra 71 12 22 66 171
Krait 42 9 9 19 79
Russell’s Viper 40 11 15 95 161
Echis 274 15 22 25 336
Total 427 47 68 205 747
Referred 46 1 2 25 74
Death 20 0 1 8 29
Mortality3.88%.
Acknowledgement• Mypatientswhoshoweddeeptrustinme
• Dr.S.K.Bichile,MyteacherandPresidentAPI
• Dr.H.S.Bawaskar,Mahad
• NeelimkumarKhaire,Herpetalogist,Pune.
• BharatCheda,Herpetalogist,Solapur.
• Dr.ShivajiWadekar,Dr.ArunMannikar,Nanded.
• Dr.SanjayLadke,Dr.V.K.Himgire,Eng.Chitmalwar,Mukhed.
• MedisunPharmaPvt.Ltd.,KrishmedPharma,Nanded.
• Mr.R.B.Deshmukh,ICT,Mukhed.
• StaffofPundeHospital&RuralHospital,Mukhed.
• Mrs.MalaPundemywife,forherstimulativeefforts.
References1. WarrellDA–GuidelinesfortheClinicalManagementofSnakebitesintheSoutheastAsianregion.Southeast–
AsianJTropMedPubHealth1999,30:1-84.
2. BawaskarHS,BawaskarPH–ProfileofSnakebiteenvenominginWesternMaharashtra,IndiaTranRSocTropMedHyg2002,:96:79-84.
3. JosephLMathew–PeadiatricsTodayVolIINo1:January–February1999(PGSeminar)
4. SnakeAFriendofHumanbeing–NeelimkumarKhaire,Pune,Maharashtra,India(MarathiBook)
5. Diagnosis and Management of Snake Venom Poisoning – Dr. J. Jacob, Varghese Publishing House, Bombay1990.
6. ReidHAChanKE.TheanPC.Prolongedcoagulationdefect (defibrination syndrome) inMalayanviperbite.Lancet1963,1:621-26
7. NeuromuscularJunctionPg.139-142fromEssentialsofMedicalPhysiology,secondeditionbyKSembulingam&PremaSembulingam.
8. Indiansnakes-NeelimkumarKhaire,Pune,Maharashtra,India(MarathiBook)
9. Snakebiteposoning,Medicineupdate-2007,349to358,H.S.Bawaskar.
Medicine UpdateVolume 18, 2008
Scientific Committee
S. K. Bichile Chairman, Scientific Committee
R. K. Singal President, Association of Physicians of India
Y. P. Munjal Dean, Indian College of Physicians
A. K. Das Dean-Elect, Indian College of Physicians
Sandhya A. Kamath Hon. General Secretary, Association of Physicians of India
Shashank R. Joshi Hon. Editor, Journal of the Association of Physicians of India
N. N. Asokan Organising Secretary, APICON-2008
MembersN. K. Hase • S. S. Mehta
Advisors
Lekha Adik PathakAK AgarwalJS BajajAK BanerjeeSK BanerjeeBR BansodePM DalalSiddhartha DasAlaka DeshpandeSB GuptaPritam GuptaRohini Handa
V. R. JoshiMA KabeerOP KalraKV KrishnadasAjay KumarSajith KumarRajat KumarHM LalRD LeleM MaiyaPC ManoriaKC Mehta
SR MehtaV MohanSK MukherjeeJ MukhopadhyayA MuruganathanG NarsimuluM PanjaPM ParikhKK PareekD RamaraoBK SahayG. S. Sainani
MA SantwaniSiddharth ShahMP SrivastavaShyam SundarPG TalwalkarK TewaryBB ThakurAK TripathySubhash VermaGS WanderME Yeolekar